We are live on ! Find out more
ELAN icon

Elanco Animal Health

376 hedge funds and large institutions have $9.85B invested in Elanco Animal Health in 2019 Q3 according to their latest regulatory filings, with 77 funds opening new positions, 158 increasing their positions, 100 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more repeat investments, than reductions

Existing positions increased: 158 | Existing positions reduced: 100

10% more first-time investments, than exits

New positions opened: 77 | Existing positions closed: 70

2% more funds holding

Funds holding: 370376 (+6)

2.91% less ownership

Funds ownership: 102.54%99.62% (-2.9%)

22% less capital invested

Capital invested by funds: $12.6B → $9.85B (-$2.79B)

43% less funds holding in top 10

Funds holding in top 10: 74 (-3)

50% less call options, than puts

Call options by funds: $24.6M | Put options by funds: $49.3M

Holders
376
Holders Change
+6
Holders Change %
+1.62%
% of All Funds
8.25%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.09%
New
77
Increased
158
Reduced
100
Closed
70
Calls
$24.6M
Puts
$49.3M
Net Calls
-$24.7M
Net Calls Change
-$20.1M
Name Holding Trade Value Shares
Change
Change in
Stake
KCM
376
Kornitzer Capital Management
Kansas
-$20.4M -603,232 Closed
STMM
377
South Texas Money Management
Texas
-$19.9M -588,773 Closed
Mackenzie Financial
378
Mackenzie Financial
Ontario, Canada
-$16.5M -489,520 Closed
N
379
Natixis
France
-$13.9M -412,552 Closed
PAM
380
Panagora Asset Management
Massachusetts
-$9.69M -286,691 Closed
SIM
381
Spark Investment Management
New York
-$7.97M -235,700 Closed
Two Sigma Investments
382
Two Sigma Investments
New York
-$7.26M -214,767 Closed
WB
383
WesBanco Bank
West Virginia
-$6.13M -181,500 Closed
BPIM
384
Brant Point Investment Management
New York
-$5.41M -160,100 Closed
QC
385
Quadrature Capital
United Kingdom
-$5.24M -154,932 Closed
SGH
386
Sivik Global Healthcare
Connecticut
-$5.07M -150,000 Closed
PWPCM
387
Perella Weinberg Partners Capital Management
New York
-$4.38M -129,496 Closed
ZDA
388
Zweig-DiMenna Associates
New York
-$4.08M -120,619 Closed
KAM
389
Kavi Asset Management
New York
-$3.95M -116,755 Closed
ET
390
Equitable Trust
Tennessee
-$3.87M -114,485 Closed
USAA
391
United Services Automobile Association
Texas
-$3.38M -99,856 Closed
Renaissance Technologies
392
Renaissance Technologies
New York
-$3.22M -95,200 Closed
AMI
393
Amica Mutual Insurance
Rhode Island
-$3.17M -93,875 Closed
FA
394
Friess Associates
Delaware
-$3.16M -93,498 Closed
BFS
395
Bradley Foster & Sargent
Connecticut
-$1.9M -56,115 Closed
AII
396
AGF Investments Inc
Ontario, Canada
-$1.69M -50,000 Closed
Tudor Investment Corp
397
Tudor Investment Corp
Connecticut
-$1.4M -41,286 Closed
CF
398
CNA Financial
Illinois
-$1.32M -39,200 Closed
AC
399
Allstate Corporation
Illinois
-$1.23M -36,488 Closed
JG
400
Jefferies Group
New York
-$1M -33,400 Closed

ELAN Hedge Fund Activity: Q3 2019 in Review

376 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q3 2019, worth a combined $9.85B — down 22% from $12.6B a quarter earlier.

Buyers outnumbered sellers: 77 funds opened new ELAN positions and 70 closed out — a net gain of 7 holders — while 158 added to existing stakes and 100 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $212M. The largest seller was T. Rowe Price Associates, cutting an estimated $153M.

  • 376 institutional investors held Elanco Animal Health (ELAN) as of Q3 2019, up from 370 in Q2 2019.
  • Funds reported $9.85B of Elanco Animal Health stock for Q3 2019, down 22% quarter-over-quarter.
  • 77 funds opened new Elanco Animal Health positions in Q3 2019 and 70 closed out, a net change of +7 holders.
  • The largest Elanco Animal Health buyer in Q3 2019 was Wellington Management Group, an estimated $212M added.
  • The largest Elanco Animal Health seller in Q3 2019 was T. Rowe Price Associates, an estimated $153M sold.

Based on aggregated 13F filings for Q3 2019.